InterventionsHuman trial
MON-206 The Efficacy of Fezolinetant for the Treatment of Vasomotor Symptoms due to Menopause in Individuals with and without Diabetes Mellitus: A Pooled Phase 3 Analysis
ENDO 2025 Abstract
The paper
Santoro NF, Blogg M, Martins K et al.
ENDO 2025 Abstract · 22 Oct 2025 · CC BY-NC-ND
Presented at ENDO 2025
